| Name | Title | Contact Details |
|---|
Strenumed Inc is a Ventura, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Ideal Protein Method is medically designed & developed, being consistent with evidence-based guidelines for weight loss management and maintenance. It is a weight loss solution for the obese and overweight patient, including those with metabolic syndrome. Ideal Protein puts forward a proven, four-part method that enables safe, effective weight loss, with a healthy lifestyle approach and a structured maintenance program to sustain weight loss success. The method targets the root causes of weight gain by reversing the imbalance of insulin that occurs with the typical Western diet. A healthier lifestyle education is a key component of all phases of the Ideal Protein Weight Loss Method, which features personalized, one-on-one coaching and a diet plan to promote losing fat while maintaining lean muscle mass. For a hospital, medical group or private medical practice, the Ideal Protein Method is a comprehensive turnkey program with no costs for training and implementation, and no long-term commitment. Offered through healthcare practitioners, trained clinics and centers, the Ideal Protein Weight Loss Method and products are now available in more than 3,000 clinics and centers throughout North America. Research demonstrating the results of the Ideal Protein Weight Loss Method has been presented at leading medical conferences such as the 9th Annual Obesity Summit at the Cleveland Clinic and the Annual Scientific Meeting of the National Obesity Society. For information on Ideal Protein, please visit our website. For details about incorporating Ideal Protein into your medical practice, visit our practitioner information pages for Physicians and Pharmacists.
New England Home Therapies is a Southborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Foxwall Emergency Medical Svc is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At T2 Biosystems, we are united in our mission: to improve patient outcomes, lower mortality rates and reduce the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. By leveraging the power of our innovative and proprietary T2 Magnetic Resonance (T2MR) platform, T2 Biosystems’ diagnostics are designed to provide faster, easier and more accurate results than traditional methodologies. T2 Biosystems is currently targeting a range of critically underserved healthcare conditions, focusing initially on those for which a rapid diagnosis will serve an important dual role – saving lives and reducing costs. Our T2Candida Panel tackles sepsis and is the first FDA-cleared diagnostic panel requiring no blood culture – delivering more accurate results in hours versus days. Other ongoing development efforts include bacterial and hemostasis panels, as well as a Lyme disease partnership with Canon Life Sciences. Over 100 studies published in peer-reviewed journals have featured T2MR technology in a breadth of applications, including the direct detection and measurement of targets in various sample types, such as whole blood, plasma, serum, saliva, sputum and urine. With limits of detection as low as 1 CFU/mL, we believe T2MR technology will drive the next generation of diagnostics.